Align succinyldiaminopimelate transaminase (EC 2.6.1.17) (characterized)
to candidate AO353_16445 AO353_16445 succinyldiaminopimelate transaminase
Query= BRENDA::Q9ZEX3 (397 letters) >FitnessBrowser__pseudo3_N2E3:AO353_16445 Length = 399 Score = 416 bits (1068), Expect = e-121 Identities = 217/395 (54%), Positives = 268/395 (67%), Gaps = 4/395 (1%) Query: 1 MNPRLDALHPYPFEKLRALLADAGKPTHDLPPINLSIGEPKHAAPACVGQAIAANLAGLS 60 MN L+ L PYPFEKLRALL A P D PI LSIGEPKH +P+ V +A+A+NL ++ Sbjct: 1 MNNALNQLQPYPFEKLRALLG-AVTPNPDKRPIALSIGEPKHRSPSFVAEALASNLDQMA 59 Query: 61 VYPSTKGEPALRQAISQWLSRRYSIPAP--DPESEVLPVLGSREALFAFAQTVIDPSAGA 118 VYP+T G PALR+AI+ W RR+ +P+ DP VLPV G+REALFAF QTV++ A Sbjct: 60 VYPTTLGIPALREAIAGWCERRFGVPSGWIDPARNVLPVNGTREALFAFTQTVVNRGDDA 119 Query: 119 LVVCPNPFYQIYEGAALLAGATPYYVNADPARDFGLRTGRVPDEVWRRTQLVFVCSPGNP 178 L+V PNPFYQIYEGAA LAGA P+Y+ F V D++W+R Q++F+CSPGNP Sbjct: 120 LIVSPNPFYQIYEGAAFLAGAKPHYLPCLDENGFNPDFDAVSDDIWKRCQILFLCSPGNP 179 Query: 179 AGNVMSLEEWRTLFELSDRHGFVIAAYECYSEIYLDEDTPPLGSLQAARRLGRDRYTNLV 238 G ++ +E + L L+D H FVIAA ECYSE+Y +E TPP G L A LGR + V Sbjct: 180 TGALIPVETLKKLIALADEHDFVIAADECYSELYFNEQTPPPGLLSACVELGRKDFKRCV 239 Query: 239 AFSSLSKRSNVPGMRSGFVAGDAALLARFLLYRTYHGSAMSPVVSAASIAAWSMRRMCR- 297 F SLSKRSN+PG+RSGFVAGDA +L FLLYRTYHG AM AS+AAW+ R Sbjct: 240 VFHSLSKRSNLPGLRSGFVAGDAEILKGFLLYRTYHGCAMPVQTQLASVAAWNDEVHVRA 299 Query: 298 KTAQYRAKFEAVLPILQNVLDVRAPQASFYLWAGTPGSDTAFARELYGRTGVTVLPGSLL 357 A YR K++AVL IL V+DV+ P FYLW G D AF R+L+ VTV+PGS L Sbjct: 300 NRALYREKYDAVLEILSPVMDVQRPDGGFYLWPNVEGDDAAFCRDLFVEEHVTVVPGSYL 359 Query: 358 AREAHNANPGQGRIRIALVAPLDQCVQAAERIAHF 392 +RE NPG GR+R+ALVAPL +CV+AAERI F Sbjct: 360 SREVDGFNPGAGRVRLALVAPLAECVEAAERIRDF 394 Lambda K H 0.321 0.135 0.412 Gapped Lambda K H 0.267 0.0410 0.140 Matrix: BLOSUM62 Gap Penalties: Existence: 11, Extension: 1 Number of Sequences: 1 Number of Hits to DB: 521 Number of extensions: 27 Number of successful extensions: 4 Number of sequences better than 1.0e-02: 1 Number of HSP's gapped: 1 Number of HSP's successfully gapped: 1 Length of query: 397 Length of database: 399 Length adjustment: 31 Effective length of query: 366 Effective length of database: 368 Effective search space: 134688 Effective search space used: 134688 Neighboring words threshold: 11 Window for multiple hits: 40 X1: 16 ( 7.4 bits) X2: 38 (14.6 bits) X3: 64 (24.7 bits) S1: 41 (21.9 bits) S2: 50 (23.9 bits)
Align candidate AO353_16445 AO353_16445 (succinyldiaminopimelate transaminase)
to HMM TIGR03538 (dapC: succinyldiaminopimelate transaminase (EC 2.6.1.17))
# hmmsearch :: search profile(s) against a sequence database # HMMER 3.3.1 (Jul 2020); http://hmmer.org/ # Copyright (C) 2020 Howard Hughes Medical Institute. # Freely distributed under the BSD open source license. # - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - # query HMM file: ../tmp/path.aa/TIGR03538.hmm # target sequence database: /tmp/gapView.16362.genome.faa # - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - Query: TIGR03538 [M=395] Accession: TIGR03538 Description: DapC_gpp: succinyldiaminopimelate transaminase Scores for complete sequences (score includes all domains): --- full sequence --- --- best 1 domain --- -#dom- E-value score bias E-value score bias exp N Sequence Description ------- ------ ----- ------- ------ ----- ---- -- -------- ----------- 5.5e-209 679.8 0.0 6.2e-209 679.6 0.0 1.0 1 lcl|FitnessBrowser__pseudo3_N2E3:AO353_16445 AO353_16445 succinyldiaminopimel Domain annotation for each sequence (and alignments): >> lcl|FitnessBrowser__pseudo3_N2E3:AO353_16445 AO353_16445 succinyldiaminopimelate transaminase # score bias c-Evalue i-Evalue hmmfrom hmm to alifrom ali to envfrom env to acc --- ------ ----- --------- --------- ------- ------- ------- ------- ------- ------- ---- 1 ! 679.6 0.0 6.2e-209 6.2e-209 1 395 [] 1 395 [. 1 395 [. 1.00 Alignments for each domain: == domain 1 score: 679.6 bits; conditional E-value: 6.2e-209 TIGR03538 1 mnpnlerlkpyPfeklaellkdvtppadleeialsiGePkhatPafvlealvenleelskyPttk 65 mn++l++l+pyPfekl++ll vtp+ d+++ialsiGePkh++P+fv+eal++nl++++ yPtt lcl|FitnessBrowser__pseudo3_N2E3:AO353_16445 1 MNNALNQLQPYPFEKLRALLGAVTPNPDKRPIALSIGEPKHRSPSFVAEALASNLDQMAVYPTTL 65 9**************************************************************** PP TIGR03538 66 GlpelreaiaeWlerrfelpag.vdperqvlPvnGtrealfafvqavidraekalvvlPnPfyqi 129 G+p+lreaia W+errf +p+g +dp+r+vlPvnGtrealfaf+q+v++r ++al+v+PnPfyqi lcl|FitnessBrowser__pseudo3_N2E3:AO353_16445 66 GIPALREAIAGWCERRFGVPSGwIDPARNVLPVNGTREALFAFTQTVVNRGDDALIVSPNPFYQI 130 ***************************************************************** PP TIGR03538 130 yeGaallagaepyflnctaengfkpdfdavpeevWkrvqllfvcsPgnPtGavlsleelkkllel 194 yeGaa+laga+p++l+c +engf+pdfdav++++Wkr+q+lf+csPgnPtGa++++e+lkkl++l lcl|FitnessBrowser__pseudo3_N2E3:AO353_16445 131 YEGAAFLAGAKPHYLPCLDENGFNPDFDAVSDDIWKRCQILFLCSPGNPTGALIPVETLKKLIAL 195 ***************************************************************** PP TIGR03538 195 adkydfiiasdecyselyldeaeaPvGlleaaaelGrddfkrllvfhslskrsnvPGlrsGfvaG 259 ad++df+ia+decysely++e+++P Gll+a+ elGr+dfkr++vfhslskrsn+PGlrsGfvaG lcl|FitnessBrowser__pseudo3_N2E3:AO353_16445 196 ADEHDFVIAADECYSELYFNEQTPPPGLLSACVELGRKDFKRCVVFHSLSKRSNLPGLRSGFVAG 260 ***************************************************************** PP TIGR03538 260 daellkeflryrtyhGcampiavqlasiaaWedekhvrenralyrekfaavleilgavldlelPd 324 dae+lk fl yrtyhGcamp+++qlas+aaW+de hvr+nralyrek++avleil++v+d+++Pd lcl|FitnessBrowser__pseudo3_N2E3:AO353_16445 261 DAEILKGFLLYRTYHGCAMPVQTQLASVAAWNDEVHVRANRALYREKYDAVLEILSPVMDVQRPD 325 ***************************************************************** PP TIGR03538 325 asfylWlkvpdgddeafaralyeeenvkvlpGrylsreaegvnPGegrvrlalvaeleecveaae 389 ++fylW++v +gdd+af+r+l+ ee+v+v+pG+ylsre++g nPG+grvrlalva+l+ecveaae lcl|FitnessBrowser__pseudo3_N2E3:AO353_16445 326 GGFYLWPNV-EGDDAAFCRDLFVEEHVTVVPGSYLSREVDGFNPGAGRVRLALVAPLAECVEAAE 389 *********.8****************************************************** PP TIGR03538 390 rikkll 395 ri++++ lcl|FitnessBrowser__pseudo3_N2E3:AO353_16445 390 RIRDFI 395 ***996 PP Internal pipeline statistics summary: ------------------------------------- Query model(s): 1 (395 nodes) Target sequences: 1 (399 residues searched) Passed MSV filter: 1 (1); expected 0.0 (0.02) Passed bias filter: 1 (1); expected 0.0 (0.02) Passed Vit filter: 1 (1); expected 0.0 (0.001) Passed Fwd filter: 1 (1); expected 0.0 (1e-05) Initial search space (Z): 1 [actual number of targets] Domain search space (domZ): 1 [number of targets reported over threshold] # CPU time: 0.02u 0.01s 00:00:00.03 Elapsed: 00:00:00.01 # Mc/sec: 7.97 // [ok]
This GapMind analysis is from Aug 03 2021. The underlying query database was built on Aug 03 2021.
Each pathway is defined by a set of rules based on individual steps or genes. Candidates for each step are identified by using ublast (a fast alternative to protein BLAST) against a database of manually-curated proteins (most of which are experimentally characterized) or by using HMMer with enzyme models (usually from TIGRFam). Ublast hits may be split across two different proteins.
A candidate for a step is "high confidence" if either:
Otherwise, a candidate is "medium confidence" if either:
Other blast hits with at least 50% coverage are "low confidence."
Steps with no high- or medium-confidence candidates may be considered "gaps." For the typical bacterium that can make all 20 amino acids, there are 1-2 gaps in amino acid biosynthesis pathways. For diverse bacteria and archaea that can utilize a carbon source, there is a complete high-confidence catabolic pathway (including a transporter) just 38% of the time, and there is a complete medium-confidence pathway 63% of the time. Gaps may be due to:
GapMind relies on the predicted proteins in the genome and does not search the six-frame translation. In most cases, you can search the six-frame translation by clicking on links to Curated BLAST for each step definition (in the per-step page).
For more information, see the paper from 2019 on GapMind for amino acid biosynthesis, the paper from 2022 on GapMind for carbon sources, or view the source code, or see changes to Amino acid biosynthesis since the publication.
If you notice any errors or omissions in the step descriptions, or any questionable results, please let us know
by Morgan Price, Arkin group, Lawrence Berkeley National Laboratory